Synek, S., & Veselý, P. (2011). Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema: Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema. Collegium antropologicum, p. 5.
Chicago stil citiranjaSynek, Svatopluk, and Petr Veselý. "Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema: Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema." 2011: 5.
MLA stil citiranjaSynek, Svatopluk, and Petr Veselý. "Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema: Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema." 2011: 5.